HUMAN LIFE SCIENCE Holding Corp. (hereafter
the " Company ") is an organization
that has been registered in the Cayman Islands
of UK. Company has established a subsidiary
in Samoa and will set up the others respectively
in Beijing, Hong Kong, Macao and Taipei (These
subsidiaries altogether are called "Group").
The great Group's goal is to become one of
the leading publicly-listed medical product
companies in Asia. Towards this goal, Group
has launched vigorous propaganda and made
great efforts in the array of market channels.
On the other hand, Group acts as the sole
importer and distributor of UKRAIN for Greater
China, a unique Cancer-Cure drug that was
developed by the NOWICKY PHARMA in Austria.
Based on a great amount of data from numerous
tests and clinical trials, UKRAIN probably
acts as a breakthrough drug which human
being has been seeking to fight against
cancer for a long time. After thirty years
from 1971 when the American ex-president
Nixon proposed "an intensive campaign
to find a cure for cancer", people
still urgently need the effective therapies
for cancers, although recent targeted therapies
seem to be a little more progressive than
traditional therapies.
There are more than 10 million new cases
of cancer worldwide and 2 million just in
Chinese Mainland every year. Total mortality
is about 60%; cancer is already the biggest
killer of those mortal diseases globally.
Furthermore, whether they are traditional
cancer therapies or new-style ones, today's
cancer therapies are highly expensive, while
their therapeutic effectiveness are always
in doubt in most case.
Under this environment，it is sure that
we will achieve great success in cancer
market of Greater China with UKRAIN which
is a breakthrough cancer therapy. Group
will only authorize the hospitals to operate
the facility "HUMAN LIFE International
Cancer Cure Center" under its supervision,
and design a set of franchising system about
the distribution of UKRAIN，Furthermore ,
Group will offer supportive services for
most of the wellknown leading hospitals
in China.
Because the cost of cancer therapy with
UKRAIN is largely lower than other available
therapies', while its effectiveness is more
outstanding, it can be estimated that UKRAIN
will quickly spread to other major cities
after primary marketing in principal cities
of China.
|
